Leigh Spielberg
Published: Friday, September 6, 2019

“Software updates have drastically improved the quality of OCT angiography (OCT-A) imaging since they were first developed,” said Professor Giovanni Staurenghi, Milan University Eye Clinic, Milan, Italy. “However, not all instruments are created equal. There are significant differences regarding what can be seen in each layer of the retina.”
Prof Staurenghi addressed delegates at the 19th Annual EURETINA Congress in Paris with his presentation, “Where do we go with OCT-A?”
Although OCT-A software improves approximately every three months, differences remain. These can be large differences, such as which scan technique is employed: spectral domain vs swept source; medium differences, like which segmentation layers are selected by the scan; or smaller differences, such as the distance between B-scans (from 5.7 to 12.9μm). Each of these can have an impact on the quality and usefulness of the resulting images.
The user can, however, experiment with settings such as brightness and contrast to obtain improved detail. Precise imaging can, for example, be used to identify amelanotic melanomas, potentially even better than with ICGA imaging.
“Although we still have some difficulties to work out, OCT-A is a fantastic instrument, and it should be added to our armamentarium for retinal disease management,” he concluded.
Tags: optical coherence tomography angiography (OCT-A)
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
Read more...
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Read more...
ESCRS Today 2025: All Eyes on Innovation
Watching out for obstacles and opportunities
Read more...
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Read more...
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Read more...
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Read more...
Supplement: ESCRS Clinical Trends Series: Presbyopia
Read more...
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Read more...
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Read more...
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Read more...